Home > Newsroom > 2007 > Notice regarding Revision to Increase Interim and Planned Annual Dividends for the Fiscal Year
Main contents starts here
November 5, 2007
Takeda Pharmaceutical Company Limited
Notice regarding Revision to Increase Interim and Planned Annual Dividends for the Fiscal Year Ending March 31, 2008
OSAKA, Japan, November 5, 2007 --- Takeda Pharmaceutical Company Limited ("Takeda") announced that its Board of Directors resolved today revision to increase the interim and planned annual dividends per share for the fiscal year ending March 31, 2008.
In order to ensure sustainable growth in corporate value, Takeda will continue to make strategic investments with the aim of enhancing its R&D pipeline in a way suitable to an R&D-oriented, world-class pharmaceutical company, and of improving its business infrastructure both in Japan and overseas.
As for profit distribution, Takada plans to buy back shares as needed, in order to improve capital efficiency and promote expeditious financial strategies, taking into consideration its overall capital requirements, as well as the stable enhancement of the dividend payout ratio.
Regarding dividend, Takeda’s basic policy, from a long-term perspective, is to maintain stable profit distribution that is appropriate to the company’s consolidated financial results. At the same time, we plan to gradually increase the consolidated dividend payout ratio, targeting around 45% in fiscal 2010, the final year of the 2006-2010 Medium-term Management Plan.
In view of the above, the interim and planned annual dividends for the fiscal year ending March 31, 2008 are revised to increase as follows:
| Interim dividend per share |
Year-end dividend per share |
Annual dividend per year |
|
| Fiscal year ending March 31, 2008 (revised) |
84.00 | 84.00 (planned) | 168.00 (planned) |
| Fiscal year ending March 31, 2008 (previous) |
80.00 | 80.00 | 160.00 |
| Fiscal year ending March 31, 2007 (actual) |
60.00 | 68.00 | 128.00 |
# # #
Forward-looking statements
This notice includes forward-looking statements regarding Takeda's plans, prospects, strategies and accomplishments, etc. These prospects are the result of assessment obtained from information currently available, and since the actual performance could be influenced by various risks and uncertainty, it shall be noted that the course of action could differ substantially from those prospects. Factors that could affect future prospects would include, but are not limited to, economic circumstances surrounding Takeda's domain identity, competitive pressures, relevant laws and regulations, change in the status of product development, exchange rate risk and so on.